Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study

Monitoring immune responses to SARS-CoV-2 vaccination and its clinical efficacy over time in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs) help to establish the optimal strategies to ensure adequate COVID-19 protection without compromising disease control offered b...

Descripción completa

Detalles Bibliográficos
Autores principales: Idda, Maria Laura, Pitzalis, Maristella, Lodde, Valeria, Loizedda, Annalisa, Frau, Jessica, Lobina, Monia, Zoledziewska, Magdalena, Virdis, Francesca, Delogu, Giuseppe, Marini, Maria Giuseppina, Mingoia, Maura, Masala, Marco, Lorefice, Lorena, Fronza, Marzia, Carmagnini, Daniele, Carta, Elisa, Pilotto, Silvy, Castiglia, Paolo, Chessa, Paola, Uzzau, Sergio, Farina, Gabriele, Solla, Paolo, Steri, Maristella, Devoto, Marcella, Fiorillo, Edoardo, Floris, Matteo, Zarbo, Roberto Ignazio, Cocco, Eleonora, Cucca, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433902/
https://www.ncbi.nlm.nih.gov/pubmed/36059537
http://dx.doi.org/10.3389/fimmu.2022.946356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433902/
https://www.ncbi.nlm.nih.gov/pubmed/36059537
http://dx.doi.org/10.3389/fimmu.2022.946356

Ejemplares similares